| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 102.49M | 81.00M | 86.98M | 73.33M | 112.80M |
| Gross Profit | 66.05M | 44.02M | 54.53M | 39.70M | 68.19M |
| EBITDA | 65.89M | 48.38M | 53.84M | 31.94M | 63.89M |
| Net Income | 37.74M | 22.22M | 27.50M | 10.76M | 38.22M |
Balance Sheet | |||||
| Total Assets | 377.84M | 333.57M | 318.28M | 326.40M | 349.76M |
| Cash, Cash Equivalents and Short-Term Investments | 129.84M | 80.05M | 63.04M | 74.97M | 98.32M |
| Total Debt | 0.00 | 1.45M | 1.75M | 14.64M | 4.16M |
| Total Liabilities | 61.89M | 59.47M | 63.91M | 93.33M | 95.88M |
| Stockholders Equity | 315.95M | 274.10M | 254.37M | 233.07M | 253.88M |
Cash Flow | |||||
| Free Cash Flow | 57.77M | 20.06M | 8.42M | 1.07M | 22.55M |
| Operating Cash Flow | 57.94M | 30.82M | 12.54M | 1.16M | 30.14M |
| Investing Cash Flow | -5.76M | -10.74M | -3.79M | -13.74M | 10.19M |
| Financing Cash Flow | -3.31M | -2.10M | -19.68M | -5.84M | -33.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$2.58B | 9.42 | 11.86% | ― | 10.53% | 26.74% | |
61 Neutral | HK$1.39B | 4.01 | 7.55% | 5.71% | 0.59% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | HK$20.91B | 14.04 | 4.37% | ― | 40.31% | 212.50% | |
48 Neutral | HK$592.37M | -8.07 | -15.30% | ― | -44.93% | 30.34% | |
46 Neutral | HK$866.58M | -3.44 | -24.48% | ― | ― | ― | |
45 Neutral | HK$232.37M | 0.25 | -1.93% | ― | -7.90% | 93.34% |
IMAX China Holding, Inc. has granted 855,166 restricted share units under its RSU scheme and 356,916 performance share units under its PSU scheme, together representing about 0.25% of the company’s issued share capital. The grants, dated 9 March 2026, cover 23 grantees, including executive director and chief executive officer Daniel Manwaring, with RSUs vesting in three equal tranches from 2027 to 2029.
The RSUs carry no purchase price and no performance targets, but are subject to clawback provisions that allow the board to cancel awards and recoup gains if participants breach non-compete or other conduct-related covenants. The move underscores the company’s use of equity-based incentives to retain key management and staff, while embedding governance safeguards around misconduct and overpayment, and does not involve any financial assistance from the company or its subsidiaries to the grantees.
The most recent analyst rating on (HK:1970) stock is a Buy with a HK$9.00 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.
IMAX China Holding announced its audited consolidated annual results for the year ended 31 December 2025, providing investors with an update on the financial performance of the group. The company also disclosed that its controlling shareholder, IMAX Corporation, has released its own fourth-quarter and full-year 2025 financial results and annual report, underscoring the close linkage between the listed unit and its parent.
In addition, IMAX China issued supplemental disclosures to its 2019, 2020 and 2023 annual reports regarding the emoluments of its former chief executive officer Edwin Tan and current chief executive officer Daniel Manwaring, in order to align with specific Hong Kong Listing Rules requirements. The enhanced transparency around senior executive compensation aims to address regulatory compliance and provide greater clarity for shareholders on governance and remuneration matters.
The most recent analyst rating on (HK:1970) stock is a Buy with a HK$9.00 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.
IMAX China Holding, Inc. has scheduled a board meeting for 25 February 2026 to review and approve the consolidated final results for the year ended 31 December 2025. The board will also consider recommending a final dividend for shareholders and address other corporate matters, signaling the upcoming release of key financial information that may influence investor expectations and capital return prospects.
The company’s announcement outlines the board’s intention to formalize its annual performance disclosure in line with market practice on the Hong Kong Stock Exchange. Any decision on a potential dividend will be closely watched as an indicator of cash generation and management’s confidence in the business outlook, with implications for stakeholder sentiment in the cinema and entertainment technology sector.
The most recent analyst rating on (HK:1970) stock is a Buy with a HK$9.00 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.
IMAX China Holding has amended its existing services agreements between IMAX Corporation and its subsidiaries IMAX Shanghai Multimedia and IMAX Hong Kong, effective 1 December 2025, to update and broaden the scope of services and the range of activities subject to variable service fees, while keeping other key terms unchanged. The board has raised the annual caps for aggregate fees payable under these services agreements to HK$20.8 million for each of 2025 and 2026, and set new annual caps of HK$4 million per year for 2026–2028 under the IMAX Shanghai Services Agreement; as these continuing connected transactions with controlling shareholder IMAX Corporation fall within the 0.1%–5% threshold of the Hong Kong Listing Rules, they are exempt from independent shareholders’ approval but remain subject to reporting and announcement requirements, with conflicted directors abstaining from the vote.
The most recent analyst rating on (HK:1970) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.
IMAX China Holding, Inc. has formalized the terms of reference for its Nomination Committee, a board committee responsible for overseeing the selection and appointment of directors. The document sets out that the committee must comprise at least three directors, with a majority being independent non-executive directors, and requires a quorum of two members including at least one independent non-executive director. The chairman of the Nomination Committee will be appointed by the board and must be either an independent non-executive director or the board chairman, and the committee must include at least one director of a different gender, aligning the company’s governance structure with Hong Kong listing and corporate governance requirements and reinforcing its commitment to board independence and diversity.
The most recent analyst rating on (HK:1970) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on IMAX China Holding stock, see the HK:1970 Stock Forecast page.